Silver Book Fact

The projected economic value of eliminating deaths from stroke is $7.6 trillion.

Murphy, Kevin M. and Robert H. Topel. Measuring the Gains from Medical Research: An economic approach. Chicago, IL: The University of Chicago Press; 2003

Reference

Title
Measuring the Gains from Medical Research: An economic approach
Publisher
The University of Chicago Press
Publication Date
2003
Authors
Murphy, Kevin M. and Robert H. Topel

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • TAVR Success in sSAS Patients
    A study of severe symptomatic aortic stenosis (sSAS) patients who received transcatheter aortic valve replacement (TAVR) found 30-day mortality of 2.2% for those who were high risk of surgical mortality/inoperable,…  
  • In the 1980s, approximately 400,000 major infarctions were occurring each year in the U.S. and 40% of patients were dying within the first year. 1-year mortality is now 4-8%.  
  • Every additional dollar spent on the routine use of beta-blockers (versus under-use) in acute heart attack patients has produced health gains valued as high as $38.44.  
  • From 1994 to 2004, death rates from cardiovascular disease declined 24.7%.  
  • Cost-effectiveness of TAVR in sSAS patients
    Patients with severe symptomatic aortic stenosis (sSAS) considered to be at high surgical risk who underwent transcatheter aortic valve replacement (TAVR) experienced lifetime incremental cost-effectiveness ratios of $55,090 per QALY…